Financhill
Back

MoonLake Immunotherapeutics Stock Predictions

One Tool. Personalized Setups.

Try it here.
Buy
66

MLTX
MoonLake Immunotherapeutics

Last Price:
$48.95
Seasonality Move:
19.44%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

MoonLake Immunotherapeutics Stock Forecast

  • Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 204.8% based on the past 4 years of stock performance.
  • MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is MoonLake Immunotherapeutics Stock Undervalued?
    The current MoonLake Immunotherapeutics [MLTX] share price is $48.89. The Score for MLTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • MLTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will MoonLake Immunotherapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 204.8% based on the past 4 years of stock performance.

MoonLake Immunotherapeutics Stock Rating

Buy
66
MoonLake Immunotherapeutics (MLTX) is a Buy

Is MoonLake Immunotherapeutics overpriced?

  • MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

MoonLake Immunotherapeutics Stock Price History

Is MLTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com

52-Week Data

52-Week High:
58.26
52-Week Low:
31.42

Prediction Charts

Market Cap:
3.1B
Price in USD:
48.89
Volume:
244.1K
Beta:
1.28

Technical Analysis

SMA50:
42.39
SMA100:
41.03
SMA200:
45.60
52-Wk Change:
15.85%

Stock Predictions

  • Is MoonLake Immunotherapeutics stock public?
    Yes, MoonLake Immunotherapeutics is a publicly traded company.
  • What is the MoonLake Immunotherapeutics stock quote today?
    The MoonLake Immunotherapeutics stock price is 48.89 USD today.
  • How to buy MoonLake Immunotherapeutics stock online?
    You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 43.36 44.21 44.43 42.97
Jun-16 44.85 42.90 44.94 42.85
Jun-17 42.39 43.00 43.29 42.22
Jun-18 43.33 43.50 44.20 42.93
Jun-20 44.00 43.50 44.00 43.04
Jun-23 43.41 44.87 44.91 43.04
Jun-24 45.23 45.76 46.18 44.67
Jun-25 46.00 47.37 47.43 45.49
Jun-26 47.69 47.29 47.69 46.39
Jun-27 47.38 47.52 48.72 46.90
Jun-30 47.82 47.20 48.49 46.99
Jul-1 47.08 46.61 47.93 46.24
Jul-2 46.67 47.86 48.02 46.32
Jul-3 48.12 48.89 49.29 47.87

MoonLake Immunotherapeutics Earnings

MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

MoonLake Immunotherapeutics Forecast Revenue Growth

MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.

* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.